- Case Reports
- Open Access
Renal leiomyoma: a case report and literature review
African Journal of Urology volume 27, Article number: 39 (2021)
Renal leiomyomas are exceptionally rare, benign, mesenchymal tumours originating from smooth muscle in the kidney. Historically, because of their small size, most renal leiomyoma cases were discovered incidentally based on autopsy findings. However, since the advent and improved access to imaging modalities such as ultrasound and computed tomography (CT), renal leiomyomas are being discovered more frequently. Although usually incidental discoveries, clinical presenting signs and symptoms comprise abdominal or flank pain, a palpable flank mass, and haematuria in 20% of those with symptoms.
We study the case of an incidentally found, asymptomatic, left kidney mass that presented in a 60-year-old female. Initial suspicions on CT imaging of either renal cell carcinoma or oncocytoma resulted in a radical nephrectomy of the left kidney. Postoperative pathological examination of the mass revealed a renal leiomyoma; a rare, benign tumour that is mostly indistinguishable from malignant tumours on imaging.
With the current availability of ultrasonography and CT, they are often discovered incidentally, and the radiological differential diagnoses are often inadequate or challenging in such cases. The gold standard management of these suspicious cancer cases is still a radical nephrectomy with postoperative pathological and immunohistochemical analysis. Due to its benign nature, patients enjoy excellent prognoses without recurrence. We discuss and briefly review the relevant literature of the clinical, imaging and pathological features of renal leiomyomas and those of the differential diagnoses.
Renal leiomyomas are exceptionally rare, benign, mesenchymal tumours originating from smooth muscle in the kidney. Renal smooth muscle can be found within the renal capsule, calyces, pelvis, and blood vessels; hence, any of these areas can be a site of origin for leiomyomas.
Steiner and colleagues found that of symptomatic leiomyomas, 53% of tumours were localised subcapsular, 37% capsular, and 10% within the renal pelvis .
Historically, because of their small size, most renal leiomyoma cases were discovered incidentally based on autopsy findings . However, since the advent and improved access to imaging modalities such as ultrasound and CT, renal leiomyomas are being discovered more frequently.
Although usually incidental discoveries, clinical presenting signs and symptoms comprise abdominal or flank pain, a palpable flank mass, and haematuria in 20% of those with symptoms. Cases suggest a higher prevalence in adult females, with an average age of 42 at presentation [1, 3]. Leiomyomas of the kidney are even rarer in the paediatric population, and there have been very few reported cases of these tumours in the literature. Some cases of interest included a six-year-old boy with an initially suspected Wilms tumour; a leiomyoma occurring in a transplanted kidney in association with the Epstein–Barr virus (EBV), five years post renal transplant; and a vascular renal leiomyoma in an 11-year-old with bilateral RCC .
Over ten years, the Brady Urological Institute reviewed several consecutive nephrectomies as a result of renal tumours. Of a total of 1030 nephrectomies, renal leiomyomas comprised 0.3% of the total, and 1.5% of all benign tumours removed .
In terms of etiological factors leading to the development of a renal leiomyoma, there are various theories and suggested causative factors. Krishnan and colleagues showed a possible causal relationship between Epstein-Barr virus and renal leiomyoma in immunocompromised patients, while Tsujimura and colleagues suggested a possible link with tuberous sclerosis; a condition more commonly associated with renal angiomyolipoma (AML) [6, 7].
When considering the relevant differential diagnosis concerning clinical presentation and imaging studies, three renal tumours that are more commonly found are AML, oncocytoma, and the diagnostic importance that lies in distinguishing them from the malignant RCC . Renal cell carcinomas make up the majority of contrast-enhancing small renal masses, the most prevalent histological type being the clear cell RCC. Frank and colleagues demonstrated a clear cell RCC incidence of 55% after 2770 surgeries (radical nephrectomies or nephron-sparing) for solid, unilateral, non-metastatic tumours .
AMLs are benign tumours in the perivascular epithelioid cell tumour family, comprising variable mixtures of thick-walled blood vessels, mature fat, and smooth muscle. It may sometimes be represented by dominance of the smooth muscle component, hence its likeness to a leiomyoma. Furthermore, they are characterised by smooth muscle and melanocytic marker (HMB-45) co-expression . In contrast to this, renal leiomyoma tumour cells typically test negative for HMB-45, but express smooth muscle actin and desmin. Angiomyolipoma is also relatively well-distinguished radiologically as an enhancing mass with macroscopic fat, devoid of calcification. Small, fat-poor tumours can be more challenging to distinguish from RCC .
Oncocytoma often displays the appearance of a well-circumscribed, homogeneous, and solid lesion, and may often demonstrate central scarring—features that are not mutually exclusive with the presentation of RCC . Postoperatively the pathologist also needs to differentiate leiomyoma from leiomyosarcoma . Histological features associated with leiomyosarcoma are tumour necrosis, nuclear pleomorphism, and increased mitotic activity .
The patient under study is a 60-year-old female, previously diagnosed with hypertension, diabetes mellitus (type II) and congestive cardiac failure. After a routine chest radiograph displayed suspicious nodularity in both lung apices, a CT was performed, and the nodules were queried to be post-infective changes or suspicious of metastases. An abdominal CT was then performed in search of a primary neoplastic lesion and a mixed, solid-cystic mass in the lower pole of the left kidney was discovered. The mass was asymptomatic, and she had no associated pain, discomfort or haematuria.
The abdominal CT showed a large solid/cystic tumour in the lower pole of the left kidney. The dimensions of the renal mass was 9 cm × 8 cm, demonstrating peripheral soft tissue enhancement with a central, cystic component measuring 12 HU (Hounsfield Units). It was highly suspicious of an RCC with central necrosis. Two months later, a repeat contrasted CT was done to evaluate for the progression of the suspicious lung lesions, which may have indicated metastases, and for the appearance of new intra-abdominal metastases. CT findings were unchanged from before, as seen in Figs. 1 and 2.
There was displacement of the lower pole of the kidney with marked compression of the proximal ureter, which was splayed around the mass—resulting in mild hydronephrosis. The mass demonstrated fat stranding and bordered the retroperitoneal fascia but did not bridge or enter the peritoneal cavity. Similarly, renal vessels were splayed but not infiltrated, with no signs of neovascularisation. There was no clear claw sign demonstrated to suggest renal origin, and no associated lymphadenopathy or distant metastases. These features were not in keeping with an aggressive RCC, and a possible diagnosis of a renal oncocytoma was considered. However, it is noted that the absence of a renal claw sign and clear origin from the renal cortex remains atypical for either of the diagnoses mentioned.
The patient was prepared for surgery and underwent a radical nephrectomy. The postoperative course was uneventful, and the patient was discharged.
Histological sections of the tumour displayed a well-circumscribed, unencapsulated mass comprising spindled cells with a fascicular growth pattern (Fig. 3). There was central cystic degeneration, associated with degenerative atypia but without any mitotic figures noted. There was no evidence of vascular invasion or necrosis. Immunohistochemically, the lesion was strongly positive for desmin and smooth muscle actin and negative for HMB-45 and melan A. Chromogenic in situ hybridisation for Epstein-Barr encoded RNA was negative, excluding EBV associated smooth muscle neoplasm, which may have similar morphology. These results, in keeping with clinically absent features of tuberous sclerosis, favoured a diagnosis of a renal leiomyoma. There was unfortunately no mention made by the histological report of whether the tumour originated from capsular or subcapsular renal tissue.
The literature reviewed comprised entirely of case studies that included a diagnosis of renal leiomyoma, within no specific time period. Provided that the diagnosis of a renal leiomyoma was made, there were no other exclusion criteria other than the patient’s age being older than 16 years—of which no such cases were eliminated thereby. Cases were reviewed and added on a case-to-case basis as they were found. Search engines utilised in English, comprised primarily of PubMed, and the university library e-databases.
We reviewed 20 cases of renal leiomyomas in adults (19 from the literature and one of our own), summarised in Table 1. The mean age was 49, with a 70% predominance of female patients. Sixty-eight per cent of these cases were symptomatic before the discovery of their renal leiomyomas. Of those cases reporting signs, 53% had abdominal pain, 32% had a flank mass, while only 26% were haematuric. Only one of nineteen presented with all three clinical features simultaneously, while 32% had at least two of the features present. In cases where tumour origin was mentioned, there was a 50% predominance of capsular leiomyomas, and only two cases were located in the subcapsular area. Of the cases that reported immunohistochemical testing, 100% of tumours tested negative for HMB-45. All the tumours that were tested for smooth muscle actin and/or desmin were positive for these markers. Tumour sizes ranged from 1.3 to 32 cm, with an average diameter of 9.6 cm.
Some of these results differ slightly from the literature represented earlier concerning presentation, which is likely due to the sample size and lack of reporting on the various clinical and pathological characteristics in many of these cases.
On ultra-sonographic imaging, leiomyomas typically appear hypoechoic with either a solid or a cystic appearance . Some helpful CT features were pointed out by Derchi and colleagues to help with the differential diagnosis. Firstly, the density before contrast of all leiomyomas displayed a likeness to that of muscle and was hyper-dense. After the addition of contrast, the masses had lower enhancement in comparison with the renal parenchyma. Secondly, the lesions display no infiltration of neighbouring tissue and are usually well-circumscribed and located peripherally. These features see the addition of a renal leiomyoma to the differential; however, malignant disease still cannot be excluded. The presence of infiltration virtually excludes a benign renal leiomyoma [1, 14].
The size and enhancement of incidentally discovered, small, asymptomatic renal masses may be of value in determining the likely nature of such lesions.
A study of 2770 renal tumours found that almost half the number of non-metastatic tumours smaller than 1 cm were benign, while tumours of 7 cm or larger comprised only 6.3% of benign tumours . O’Connor and colleagues discovered incidental renal lesions greater than 1 cm in 433 of 3001 (14%) in asymptomatic adults after an abdominopelvic CT for screening colonography. Of these, 87% were radiologically characterised as benign and a further 13% of “indeterminate significance” . Radiologically, the enhancement of a renal lesion is considered a valuable characteristic in determining the nature of the lesion. While there is some consensus that enhancement of 20 HU or more is significant in identifying malignant lesions, some authors suggest that lesions displaying 10 HU or more should still be considered significantly suspicious of malignancy. Therefore, lesions displaying attenuation from 10 HU to 19 HU are considered “indeterminate”.
This determination has some implications when considering the possibility of pre-operative diagnosis in the form of CT-guided core biopsies. Although it remains controversial, Eshed and colleagues believe that due to the low complication rate and value in implementing disease-tailored management, indication for core biopsies should include radiographically indeterminate lesions and small renal masses. In agreement, Romero and colleagues suggest that there is a place for biopsy and conservative management in patients with radiographic and clinical evidence of a diagnosis other than RCC. These lesions with benign biopsy results can then undergo resection, re-evaluation or close clinical or imaging surveillance [5, 16]. Where availability and resources allow for such, the use of Magnetic Resonance Imaging (MRI) in the diagnosis of renal masses is another area of diagnostics which may benefit pre-operative diagnostics. However, in a resource-poor setting, this modality is a less feasible option than CT due to limited availability in the public sector, and cost. It is thus not further discussed in this paper.
Currently, management of larger lesions still holds surgical resection as its gold standard, with radical nephrectomy being the usual approach to suspicious lesions. Lesions equal to, or smaller than, 4 cm allow consideration for nephron-sparing resections, and smaller renal masses can be biopsied—although still considered a somewhat controversial practice . In the ideal setting, nephron-sparing resection could also be a consideration, given the availability of extemporaneous examination during the surgical procedure. Likewise, the same remains true with regard to performing an initial renal biopsy for immunohistological diagnosis. The indications for either of which would also need to be correlated with pre-operative imaging findings.
Accurate detection of renal leiomyomas may be challenging in the pre-operative setting, given the variety of findings on imaging. There are very few characteristics that may help rule in or rule out the leiomyoma amongst its differential, especially when suspicious or malignant lesions have to be considered. Pre-operative, image-guided core biopsy would undoubtedly aid in distinguishing the leiomyoma. However, its use is dependent on multiple factors ranging from clinical presentation to size and contrast enhancement of the lesion, and availability of resources. In addition to being viewed as a controversial practice, the place for biopsy in the resource-poor setting is yet to be determined. Until more rigid indications are established surrounding conservative treatment, definitive management will invariably be surgical, as these patients enjoy an excellent prognosis without recurrence.
Availability of data and materials
Data sharing does not apply to this article as no datasets were generated or analysed during the current study.
Renal cell carcinoma
Steiner M, Quinlan D, Goldman S, Millmond S, Hallowell M, Stutzman R et al (1990) Leiomyoma of the kidney: presentation of 4 new cases and the role of computerized tomography. J Urol 143(5):994–998
Belis J, Post G, Rochman S, Franklin MD (1979) Genitourinary leiomyomas. Urology 13(4):424–429
Andreoiu M, Drachenberg D, Macmahon R (2009) Giant renal leiomyoma: a case report and brief review of the literature. Can UrolAssoc J 3(5):58–60
Nakib G, Mahgoub N, Calcaterra V, Pelizzo G (2017) Renal leiomyoma in pediatric age: a rare case report with review of the literature. J PediatrSurg Case Rep 27:43–46
Romero F, Kohanim S, Lima G, Permpongkosol S, Fine S, Kavoussi L (2005) Leiomyomas of the kidney: emphasis on conservative diagnosis and treatment. Urology 66(6):1319.e1–3
Krishnan R, Freeman J, Creager A (1999) Epstein–Barr virus induced renal leiomyoma. J Urol 161(1):212
Tsujimura A, Miki T, Sugao H, Takaha M, Takeda M, Kurata A (1996) Renal leiomyoma associated with tuberous sclerosis. UrolInt 57(3):192–193
Nagar A, Raut A, Narlawar R, Bhatgadde V, Rege S, Thapar V (2004) Giant renal capsular leiomyoma: study of two cases. Br J Radiol 77(923):957–958
Frank I, Blute M, Cheville J, Lohse C, Weaver A, Zincke H (2003) Solid renal tumors: an analysis of pathological features related to tumor size. J Urol 170(6 Pt 1):2217–2220
Brunocilla E, Pultrone C, Schiavina R, Vagnoni V, Caprara G, Martorana G (2012) Renal leiomyoma: case report and literature review. Can UrolAssoc J 6(2):E87-90
Kim J, Park S, Shon J, Cho K (2004) Angiomyolipoma with minimal fat: differentiation from renal cell carcinoma at biphasic helical CT. Radiology 230(3):677–684
Perez-Ordonez B, Hamed G, Campbell S, Erlandson RA, Russo P, Gaudin PB et al (1997) Renal oncocytoma: a clinicopathologic study of 70 cases. Am J SurgPathol 21(8):871–883
Hogan A, Smyth G, D’Arcy C, O’Brien A, Quinlan D (2008) Renal capsular leiomyoma. Urology 71(6):1226.e1–3
Derchi L, Grenier N, Heinz-Peer G, Dogra V, Franco F, Rollandi G et al (2008) Imaging of renal leiomyomas. ActaRadiol 49(7):833–838
O’Connor S, Pickhardt P, Kim D, Oliva M, Silverman S (2011) Incidental Finding of renal masses at unenhanced CT: prevalence and analysis of features for guiding management. Am J Roentgenol 197(1):139–145
Eshed I, Elias S, Sidi A (2004) Diagnostic value of CT-guided biopsy of indeterminate renal masses. ClinRadiol 59(3):262–267
Mitra B, Debnath S, Pal M, Paul B, Saha T, Maiti A (2012) Leiomyoma of kidney: an Indian experience with literature review. Int J Surg Case Rep 3(11):569–573
Larbcharoensub N, Limprasert V, Pangpunyakulchai D, Sanpaphant S, Wiratkapun C, Kijvikai K (2017) Renal leiomyoma: a case report and review of the literature. Urol Case Rep 7(13):3–5
Akbulut F, Şahan M, Üçpınar B, Savun M, Özgör F, Arslan B et al (2016) A rare case of renal leiomyoma treated with laparoscopic partial nephrectomy. Med Bull Haseki 54(1):41–43
Kocak C, Kabay S, Isler B (2015) Leiomyoma of the renal vein: a rare tumor presenting as a renal mass. Case Rep Urol 5(2015):1–3
Lal A, Galwa R, Chandrasekar P, Sachdeva M, Vashisht R, Khandelwal N (2009) A huge renal capsular leiomyoma mimicking retroperitoneal sarcoma. Saudi J Kidney Dis Transpl 20(6):1069–1071
Takezaki T, Nakama M, Ogawa A (1985) Renal leiomyoma with extensive cystic degeneration. Urology 25(4):401–403
Fu L, Humphrey P, Adeniran A (2015) Renal leiomyoma. J Urol 193(3):997–998
Patil P, McKenney J, Trpkov K, Hes O, Montironi R, Scarpelli M et al (2015) Renal leiomyoma: a contemporary multi-institution study of an infrequent and frequently misclassified neoplasm. Am J SurgPathol 39(3):349–356
No funding was received for this study.
Ethics approval and consent to participate
Ethics approval was obtained from the Health Research Ethics Committee of Stellenbosch University with the reference number of UC19/10/048. Consent to participate is not applicable.
Consent for publication
Written informed consent for publication of the patient’s clinical details and clinical images was obtained from the patient.
The authors declare that they have no competing interests.
About this article
Cite this article
Gerdharee, S., van Wyk, A., van Deventer, H. et al. Renal leiomyoma: a case report and literature review. Afr J Urol 27, 39 (2021). https://doi.org/10.1186/s12301-021-00143-z
- Renal leiomyoma
- Case report
- Renal leiomyoma diagnosis
- Literature review
- Renal leiomyoma imaging